Intellia Therapeutics Statistics
Total Valuation
NTLA has a market cap or net worth of $2.83 billion. The enterprise value is $1.67 billion.
Important Dates
The next estimated earnings date is Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NTLA has 107.35 million shares outstanding. The number of shares has increased by 10.38% in one year.
| Current Share Class | 107.35M |
| Shares Outstanding | 107.35M |
| Shares Change (YoY) | +10.38% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 1.60% |
| Owned by Institutions (%) | 87.99% |
| Float | 101.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 39.65 |
| Forward PS | 37.64 |
| PB Ratio | 3.01 |
| P/TBV Ratio | 3.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 31.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.19, with a Debt / Equity ratio of 0.14.
| Current Ratio | 5.19 |
| Quick Ratio | 4.93 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -56.95% and return on invested capital (ROIC) is -33.77%.
| Return on Equity (ROE) | -56.95% |
| Return on Assets (ROA) | -30.62% |
| Return on Invested Capital (ROIC) | -33.77% |
| Return on Capital Employed (ROCE) | -63.73% |
| Revenue Per Employee | $131,159 |
| Profits Per Employee | -$1.19M |
| Employee Count | 403 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +45.91% in the last 52 weeks. The beta is 2.38, so NTLA's price volatility has been higher than the market average.
| Beta (5Y) | 2.38 |
| 52-Week Price Change | +45.91% |
| 50-Day Moving Average | 13.49 |
| 200-Day Moving Average | 10.63 |
| Relative Strength Index (RSI) | 85.90 |
| Average Volume (20 Days) | 7,202,021 |
Short Selling Information
The latest short interest is 34.14 million, so 31.80% of the outstanding shares have been sold short.
| Short Interest | 34.14M |
| Short Previous Month | 27.74M |
| Short % of Shares Out | 31.80% |
| Short % of Float | 33.49% |
| Short Ratio (days to cover) | 8.38 |
Income Statement
In the last 12 months, NTLA had revenue of $52.86 million and -$480.19 million in losses. Loss per share was -$4.68.
| Revenue | 52.86M |
| Gross Profit | -387.25M |
| Operating Income | -512.02M |
| Pretax Income | -480.19M |
| Net Income | -480.19M |
| EBITDA | -501.87M |
| EBIT | -512.02M |
| Loss Per Share | -$4.68 |
Full Income StatementBalance Sheet
The company has $459.65 million in cash and $102.59 million in debt, giving a net cash position of $527.92 million or $4.92 per share.
| Cash & Cash Equivalents | 459.65M |
| Total Debt | 102.59M |
| Net Cash | 527.92M |
| Net Cash Per Share | $4.92 |
| Equity (Book Value) | 715.26M |
| Book Value Per Share | 6.79 |
| Working Capital | 400.45M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$418.58 million and capital expenditures -$3.23 million, giving a free cash flow of -$421.82 million.
| Operating Cash Flow | -418.58M |
| Capital Expenditures | -3.23M |
| Free Cash Flow | -421.82M |
| FCF Per Share | -$3.93 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -968.69% |
| Pretax Margin | -908.48% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NTLA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.38% |
| Shareholder Yield | -10.38% |
| Earnings Yield | -21.88% |
| FCF Yield | -19.22% |
Dividend DetailsAnalyst Forecast
The average price target for NTLA is $30.47, which is 15.42% higher than the current price. The consensus rating is "Buy".
| Price Target | $30.47 |
| Price Target Difference | 15.42% |
| Analyst Consensus | Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 100.54% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NTLA has an Altman Z-Score of -0.27 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.27 |
| Piotroski F-Score | 3 |
